MYNZ
Mainz Biomed BV
NASDAQ: MYNZ · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.41
-3.73% today
Updated 2026-05-01
Market cap
$7.90M
P/E ratio
—
P/S ratio
16.01x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$1 – $5
Volume
0.8M
Mainz Biomed BV (MYNZ) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-28.22%
ROE
-4.66%
ROA
-1.14%
Debt/equity
1.23x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $281393.00 | $-957055.00 | -21.77% | -327.62% | -340.11% |
| 2020 | $493565.00 | $-586895.00 | 24.94% | -155.22% | -118.91% |
| 2021 | $577348.00 | $-11.69M | 30.77% | -1,684.36% | -2,024.79% |
| 2022 | $529877.00 | $-26.45M | 34.38% | -4,990.60% | -4,992.24% |
| 2023 | $895479.00 | $-26.30M | 56.91% | -2,975.47% | -2,936.50% |
| 2024 | $893991.00 | $-21.65M | 64.31% | -2,091.23% | -2,421.80% |